Kapspargo Sprinkle (Metoprolol Succinate) Patent Expiration, LOE Window & CMS Spending

Kapspargo Sprinkle (Metoprolol Succinate) by Sun Pharmaceutical: FDA Orange Book LOE 2035-07-09, 26 AB generics, $4.0M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSun Pharmaceutical
FDA Application & PathwayN210428 (NDA)
Exclusivity / Cliff HorizonMid-Term Protection (2031-2035)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2035-07-09
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors26
2024 CMS Total Public Spend$4.0M
2024 Medicare Part D Spend$2.6M
2024 Medicaid Spend$1.3M
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 17.4% 2-yr change)